Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

BioRem Inc. (BIRMF)

Other OTC - Other OTC Delayed Price. Currency in USD
0.76000.0000 (0.00%)
At close: 12:06PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.7600
Open0.7600
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.7600 - 0.7600
52 Week Range0.1500 - 0.7600
Volume5
Avg. Volume453
Market Cap11.778M
Beta (5Y Monthly)0.62
PE Ratio (TTM)12.67
EPS (TTM)0.0600
Earnings DateNov 15, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for BIRMF

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • BIOREM INC
    CLH: Lowering target price to $140.00CLEAN HARBORS INC has an Investment Rating of HOLD; a target price of $140.000000; an Industry Subrating of High; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Low.
    Rating
    Fair Value
    Economic Moat
    2 days agoArgus Research
View more
  • PR Newswire

    Biorem Reports Third Quarter Results & Increases in Revenues and Earnings

    BIOREM Inc. (TSXV: BRM) ("Biorem" or "the Company") today announced its results for the three and nine-month periods ended September 30, 2022. Biorem's complete third quarter financial statements and MD&A have been filed on SEDAR (www.sedar.com).

  • CNW Group

    New growth initiatives drive BIOREM order backlog to record $44.5M

    BIOREM Inc. (TSXV: BRM) ("Biorem" or "the Company") today announced several new orders totalling $7.1 million. The orders are for air emission abatement projects in North America and continue to increase BIOREM's order backlog to a record $44.5 million, its highest point since the Company was founded in 1990.

  • CNW Group

    Biorem Reports Second Quarter Results & Record Order Backlog

    BIOREM Inc. (TSXV: BRM) ("Biorem" or "the Company") today announced its results for the three and six-month periods ended June 30, 2022. Biorem's complete second quarter financial statements and MD&A have been filed on SEDAR (www.sedar.com).

Advertisement
Advertisement